Use of escitalopram (the S-(+)-enantiomer of citalopram) or a pharmaceutically acceptable salt thereof for the preparation of a medicament useful in the treatment of neurotic disorders is provided, including anxiety states, in particular generalised anxiety disorder and social anxiety disorder, post traumatic stress disorder, obsessive compulsive disorder and panic attacks.

 
Web www.patentalert.com

< Composition comprising camptothecin or a comptothecin derivative and a platin derivative for the treatment of cancer

< Tumor specific monoclonal antibodies

> Anti-TRAIL-R antibodies

> Intracellular delivery of biological effectors

~ 00217